This condition affects up to 2% of postmenopausal women [4,5] and is marked by hypercalcemia paired with elevated or inadequately suppressed levels of parathyroid hormone, primarily due to a solitary parathyroid adenoma in 85-90% of cases [6,7]. The gene discussed is PTH; the disease is Hypercalcemia.